Bex, Axel <br/><br/>
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.  [electronic resource] 

 -  World journal of urology  Aug 2009 
 - 533-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-8726 
<br/><br/><label>Standard No.: </label>10.1007/s00345-008-0368-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Indoles--therapeutic use<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Nephrectomy--methods<br/>Pyrroles--therapeutic use<br/>Retrospective Studies<br/>Sunitinib<br/>Treatment Outcome